Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-05-07 @ 1:21 PM
Study NCT ID:
NCT04575961
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-23
First Post:
2020-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
Sponsor:
North Eastern German Society of Gynaecological Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NOGGO-ov44
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |